female patients aged more than or equal 18 year diagnosed with breast cancer
metastatic and non-metastatic cancer premenopausal and postmenopausal female positive and negative hormonal receptors and HER2 receptor taking any systemic treatment taking radiotherapy or not
You may not be if
female patients less than 18 years patients having comorbid disease. patients with double malignancy
Clareo Health | Prognostic Value of Some Biochemical Markers in Breast Cancer
